Resolution
|
Total votes for(1)(2)
|
%
|
Total votes against(2)
|
%
|
Total votes cast
|
Votes withheld(3)
|
|
1
|
Receive and adopt the 2019 Annual Report
|
3,600,444,466
|
99.14
|
31,207,913
|
0.86
|
3,631,652,379
|
10,956,841
|
2
|
Approve the Annual report on remuneration
|
3,420,333,315
|
94.53
|
197,813,171
|
5.47
|
3,618,146,486
|
24,463,063
|
3
|
To approve the Remuneration policy
|
2,665,161,732
|
88.18
|
357,360,021
|
11.82
|
3,022,521,753
|
620,087,463
|
4
|
Election of Sir Jonathan Symonds
|
3,608,718,661
|
99.35
|
23,502,289
|
0.65
|
3,632,220,950
|
10,386,063
|
5
|
Election of Charles Bancroft
|
3,627,334,204
|
99.87
|
4,856,095
|
0.13
|
3,632,190,299
|
10,417,951
|
6
|
Re-election of Emma Walmsley
|
3,627,591,812
|
99.84
|
5,958,848
|
0.16
|
3,633,550,660
|
9,058,990
|
7
|
Re-election of Vindi Banga
|
3,610,251,798
|
99.39
|
22,061,718
|
0.61
|
3,632,313,516
|
10,290,761
|
8
|
Re-election of Dr Hal Barron
|
3,626,272,920
|
99.83
|
6,065,354
|
0.17
|
3,632,338,274
|
10,268,248
|
9
|
Re-election of Dr Vivienne Cox
|
3,610,563,927
|
99.39
|
21,999,262
|
0.61
|
3,632,563,189
|
10,044,077
|
10
|
Re-election of Lynn Elsenhans
|
3,625,704,253
|
99.82
|
6,692,345
|
0.18
|
3,632,396,598
|
10,211,321
|
11
|
Re-election of Dr Laurie Glimcher
|
3,627,888,440
|
99.87
|
4,570,015
|
0.13
|
3,632,458,455
|
10,149,465
|
12
|
Re-election of Dr Jesse Goodman
|
3,627,512,409
|
99.87
|
4,791,872
|
0.13
|
3,632,304,281
|
10,303,639
|
13
|
Re-election of Judy Lewent
|
3,555,987,248
|
97.90
|
76,330,162
|
2.10
|
3,632,317,410
|
10,290,509
|
14
|
Re-election of Iain Mackay
|
3,589,348,335
|
98.83
|
42,624,938
|
1.17
|
3,631,973,273
|
10,634,976
|
15
|
Re-election of Urs Rohner
|
3,566,736,006
|
98.27
|
62,967,560
|
1.73
|
3,629,703,566
|
10,694,898
|
16
|
Re-appointment of the auditor
|
3,629,594,188
|
99.89
|
4,085,942
|
0.11
|
3,633,680,130
|
8,926,613
|
17
|
Remuneration of auditor
|
3,628,076,303
|
99.86
|
4,927,253
|
0.14
|
3,633,003,556
|
9,605,108
|
18
|
Authority for the company to make donations to political
organisations and incur political expenditure
|
3,535,034,521
|
97.51
|
90,339,692
|
2.49
|
3,625,374,213
|
17,230,899
|
19
|
Authority to allot shares
|
3,486,912,340
|
96.08
|
142,428,115
|
3.92
|
3,629,340,455
|
13,259,348
|
20
|
Disapplication of pre-emption rights - general
power(4)
|
3,551,097,589
|
97.88
|
76,802,232
|
2.12
|
3,627,899,821
|
14,698,767
|
21
|
Disapplication of pre-emption rights - in connection with an
acquisition or specified capital investment(4)
|
3,547,842,037
|
97.88
|
76,869,347
|
2.12
|
3,624,711,384
|
17,887,616
|
22
|
Authority for the company to purchase its own
shares(4)
|
3,564,497,165
|
98.16
|
66,913,063
|
1.84
|
3,631,410,228
|
11,196,094
|
23
|
Exemption from statement of senior statutory auditor's
name
|
3,584,838,016
|
98.78
|
44,131,049
|
1.22
|
3,628,969,065
|
13,635,791
|
24
|
Authority for reduced notice of a general meeting other than an
AGM(4)
|
3,354,669,411
|
92.41
|
275,453,838
|
7.59
|
3,630,123,249
|
12,478,713
|
(1)
|
The "for" votes include those giving the Chairman discretion. In
line with the notification issued to American Depositary Receipt
(ADR) holders last year, GSK did not instruct its ADR Depositary to
vote any unvoted ADRs in respect of the AGM
resolutions.
|
(2)
|
Votes "for" and "against" are expressed as a percentage of the
total votes cast.
|
(3)
|
A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a
resolution.
|
(4)
|
Indicates Special Resolutions requiring a 75%
majority.
|
|
GSK's
Twentieth
AGM
(2020)
|
GSK's
Nineteenth
AGM
(2019)
|
Issued share capital (excluding Treasury Shares)
|
5,017,091,542
|
4,987,806,108
|
Total votes cast and votes withheld lodged as a % of GSK's issued
share capital (excluding
Treasury Shares)
|
72.60%
|
71.49%
|
Total shareholder population
|
105,353
|
108,698
|
Total number of proxies lodged
|
6,268
|
6,635
|
% of shareholders who lodged proxies
|
5.95%
|
6.10%
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
06, 2020
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|